Operating Lease, Right-of-Use Asset of Syndax Pharmaceuticals Inc from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Syndax Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • Syndax Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $1,342,000, a 34% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Syndax Pharmaceuticals Inc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,342,000 -$680,000 -34% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $1,471,000 +$715,000 +95% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $1,629,000 +$629,000 +63% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $1,801,000 +$558,000 +45% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $2,022,000 +$535,000 +36% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $756,000 -$975,000 -56% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $1,000,000 -$968,000 -49% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $1,243,000 +$314,000 +34% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $1,487,000 +$448,000 +43% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $1,731,000 +$579,000 +50% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $1,968,000 +$1,194,000 +154% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $929,000 +$56,000 +6.4% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $1,039,000 +$56,000 +5.7% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $1,152,000 +$59,000 +5.4% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $774,000 +$436,000 +129% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $873,000 +$439,000 +101% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $983,000 +$693,000 +239% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $1,093,000 +$697,000 +176% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $338,000 -$164,000 -33% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $434,000 -$174,000 -29% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $290,000 -$426,000 -59% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $396,000 -$430,000 -52% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $502,000 -$585,000 -54% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $608,000 -$600,000 -50% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $716,000 -$584,000 -45% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $826,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $1,087,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $1,208,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $1,300,000 01 Jan 2019 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.